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Abstract: Exhaled breath is a potential noninvasive matrix to give new information about metabolic
effects of diets. In this pilot study, non-targeted analysis of exhaled breath volatile organic compounds
(VOCs) was made by comprehensive two-dimensional gas chromatography–mass spectrometry
(GCxGC-MS) to explore compounds relating to whole grain (WG) diets. Nine healthy subjects
participated in the dietary intervention with parallel crossover design, consisting of two high-fiber
diets containing whole grain rye bread (WGR) or whole grain wheat bread (WGW) and 1-week control
diets with refined wheat bread (WW) before both diet periods. Large interindividual differences
were detected in the VOC composition. About 260 VOCs were detected from exhaled breath samples,
in which 40 of the compounds were present in more than half of the samples. Various derivatives of
benzoic acid and phenolic compounds, as well as some furanones existed in exhaled breath samples
only after the WG diets, making them interesting compounds to study further.
Keywords: exhaled breath; whole grain; rye; comprehensive two-dimensional gas chromatography–
mass spectrometry; dietary fiber
1. Introduction
Whole grain (WG) cereals are an important source of dietary fiber (DF) and micronu-
trients and are therefore acknowledged as part of the healthy diet in dietary recommen-
dations [1,2]. Epidemiological studies and their meta-analyses have consistently shown
high intake of WG to lower risk of chronic diseases and mortality [3–5], and associate
negatively with obesity [6,7], type 2 diabetes [8–10], cardiovascular disease [11–13], and
certain cancers [14,15]. However, the underlying physiological mechanisms are complex
and unclear. Phenolic compounds in the fiber matrix of bran [16] are one proposed element
for the protective effects of WG. Alkylresorcinols are present in the outer layers of wheat
and rye grains and are known to be absorbed by humans. They have been detected in
plasma and urine, and hence have been studied as a promising biomarker for WG wheat
and rye in the diet [17].
People have variable metabolic responses to diets because of individual physiology
and gut microflora [18]. Therefore, there has been an increasing interest in nutrigenomics,
proteomics, and metabolomics to monitor metabolism from a wider perspective. Volatomic
analysis of exhaled breath, used mainly for searching noninvasive biomarkers for dis-
eases [19–21], could be used to characterize volatile organic compounds (VOCs) relating
to various diets or specific foods, such as WG cereals. This research could lead to new
information on the metabolic effects of WG foods and their association with health effects.
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Exhaled breath is a potential noninvasive matrix to monitor metabolic changes induced
by dietary modifications [22,23]. Foods contain numerous molecules which after digestion
or metabolism by gut microflora are absorbed to the circulation. If they have a suitable
boiling point, vapor pressure, and solubility, they can be excreted to exhaled breath.
Currently, more than 3400 compounds have been identified in exhaled breath [24,25],
with an average exhaled breath sample containing about 200 detected compounds [26].
However, there is wide interindividual variation since typically only a few dozen of the
compounds are detected in every exhaled breath sample.
Although diet is known to cause variation in exhaled compounds [27], so far only a few
pilot studies have been conducted to monitor the effects of diets on exhaled breath VOCs.
Pioneering research in developing methods for exhaled breath analysis was done by Smith
and Španěl who explored the effects of a meal [28] and glucose ingestion [29] to exhaled
breath VOCs, as well as the effects of ketogenic diet on breath acetone levels [30]. Galassetti,
Blake and colleagues studied exhaled breath compounds relating to diabetes [31,32] and
monitored the effects of high-fat meals on exhaled breath VOCs [33]. They also studied
exhaled breath VOC profiles relating to blood glucose [34–36] and lipid levels [37]. van
Schooten et al. applied the breath analysis to monitor gastrointestinal diseases [38–40] and
demonstrated a distinctive exhaled breath VOC profile after a gluten-free diet [41].
We have earlier demonstrated changes in exhaled breath VOC profiles by aspiration
ion mobility spectrometry (AIMS) in diets differing in DF content (low-fiber diet vs. high-
fiber) and type of bread (white wheat bread vs. sourdough fermented whole grain rye
bread vs. white wheat bread enriched with modified rye fiber) [42,43]. However, the AIMS
technology, regarded as a type of electronic nose, cannot identify the compounds respon-
sible for the changes. Gas chromatography–mass spectrometry (GC-MS) is a standard
technology for identifying VOCs [24,44] and multidimensional chromatography techniques,
such as comprehensive two-dimensional GC-MS (GCxGC-MS), are utilized especially for
characterization of compounds in metabolomic research, due to their increased separation
capability [45]. However, they are not yet utilized for monitoring exhaled breath VOCs
regarding to diets.
In this study, our aim was to pilot exhaled breath analysis with GCxGC-MS to explore
VOCs relating to WG diets.
2. Results
About 260 VOCs were detected in 32 exhaled breath samples from 9 persons; of these
VOCs, 40 were common, being present in more than half of the breath samples (Table 1).
Carbon dioxide, isoprene, acetone, ethanol, 1-butanol, 2-propanol, benzene, benzaldehyde,
methyl vinyl ketone, 2-butanone, phenol, hexanoic acid, and acetonitrile were found in all
samples, but large individual differences existed in the other compounds. Additionally,
86 VOCs were tentatively identified by their MS spectra (Table S1), whereas about 170
detected compounds remained unidentified.
Some derivatives of benzoic acid and phenolic compounds were detected in exhaled
breath samples only after the WG diets (Table 2). Phthalic acid or phthalic anhydride
(similarity index, SI 93 for both compounds) was found in 57% of the exhaled breath
samples during the whole grain rye bread diet (WGR), in 11% of breath samples during the
whole grain wheat bread diet (WGW), and in 6% of the background room air (BG) samples,
but in none of the samples collected after the control diets containing refined wheat bread
(WW). Benzoic acid was detected in 29% of breath samples during the WGR diet and in
11% of breath samples during the WGW diet, but in none of the exhaled breath samples
during the WW diets and in 6% of BG samples. Furthermore, diphenyl ethanedione and
benzamide were detected only after the WG diets, diphenyl ethanedione in 29% of breath
samples during the WGR and benzamide in one participant during the WGR and the
WGW.
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Table 1. Common 1 volatile compounds in the exhaled breath samples collected from the study
participants after the diet periods and their presence in the background room air samples.
Detected in % of Samples in
Compounds WGR WGW WW BG
Carbon dioxide 100 100 100 100
Ethanol 100 100 100 100
Hexanoic acid 100 100 100 100
Acetophenone 100 100 100 100
1-Butanol 100 100 100 97
Benzene 100 100 100 97
Benzaldehyde 100 100 100 97
Methyl vinyl ketone 100 100 100 97
2-Butanone 100 100 100 97
Acetone 100 100 100 94
Phenol 100 100 100 94
2-Propanol 100 100 100 90
Acetonitrile 100 100 100 87
Isoprene 100 100 100 42
2,3-Butanedione 100 89 100 68
Toluene 100 33 81 74
3-Pentanol/2-Propanol, 2-methyl 86 100 100 97
Butanal 86 100 100 87
Hexanal 86 100 88 87
Heptanal 86 100 81 74
Octanal 86 89 94 23
Benzaldehyde, 2/4-methyl 86 89 75 90
Pentanal 86 89 69 68
n-Hexane 86 67 88 58
Nonanal 71 78 100 94
Acetaldehyde 71 56 81 77
3,4-Dimethyl heptane 71 33 75 35
D-Limonene 71 33 69 10
1,3-Pentadiene 71 33 69 0
Benzene, 1,4-dimethyl- 71 22 56 26
Dimethyl sulfide 57 78 81 0
Decanal 57 67 56 84
Methyl cyclopentane 57 56 63 42
6-Methyl-5-hepten-2-one 57 56 88 68
1-Propanol 57 44 81 39
Octane 57 44 56 17
Ethyl acetate 57 33 75 71
Styrene 57 33 69 29
p-Cymene 57 33 69 3
Heptane 43 56 75 71
1 present in >50% of the analyzed exhaled breath samples, WGR = whole grain rye bread diet (n = 7),
WGW = whole grain wheat bread diet (n = 9), WW = refined wheat bread diet (n = 16), BG = background
room air (n = 31).
Some furanones (G-lactones) were also identified in the exhaled breath only dur-
ing the WG diets: 5-dodecyldihydro-(3H)-furanone (in two participants after WGR),
dihydro-4-hydroxy-2(3H)-furanone (in one participant after WGR and WGW) and dihydro-
5-tetradecyl-2(3H)-furanone (in one participant after WGR and WGW).
We also detected several unidentified compounds having mass spectrum fragments
105, 77 and 51, which are typical for benzoic acid derivatives, and 107, 121, 135, and 149,
typical for alkylphenols (potential degradation products of alkylresorcinols). However,
none of the unidentified compounds were detected only in a particular diet period.
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Table 2. Volatile organic compounds detected only in the exhaled breath samples after WG diets.
Detected in % of Samples in
Compounds RT SI WGR WGW WW BG
Phthalic acid/Phthalic anhydride 40–69 93 57 11 0 6
Benzoic acid 30–69 94 29 11 0 6
Diphenyl ethanedione 61.7 92 29 0 0 0
5-Dodecyldihydro-(3H)-furanone 63.7 92 29 0 0 0
Benzamide 65.5 94 14 11 0 0
Dihydro-4-hydroxy-2(3H)-furanone 57.5 85 14 11 0 0
Dihydro-5-tetradecyl-2(3H)-furanone 67.7 89 14 11 0 0
RT = retention time (min), SI = similarity index, WGR = whole grain rye bread diet (n = 7), WGW = whole grain
wheat bread diet (n = 9), WW = white wheat bread diet (n = 16), BG = background room air (n = 31).
3. Discussion
We piloted exhaled breath analysis with GCxGC-MS to detect VOCs relating to WG
diets. With this technology and the chosen method, about 260 compounds were detected
from exhaled breath samples, and of these, 40 VOCs were present in more than half of the
exhaled breath samples. Some benzoic acid and phenol derivatives, as well as furanone
compounds, were detected more frequently after the whole grain diets.
GCxGC-MS-technology has better sensitivity and separation of compounds as com-
pared to the traditional GC-MS, which make it suitable for non-targeted analysis of exhaled
breath compounds. We have earlier analyzed exhaled breath VOCs by traditional GC-MS
having the same column and same kind of sampling protocol [46], and about 40 VOCs
were detected in the exhaled breath samples collected from healthy men. In the current
GCxGC-MS protocol, the total number of detected compounds was approximately seven
times more (about 260 compounds). The comprehensive GCxGC-MS technology is based
on cryogenic modulator: effluent from the first column is trapped in the modulator for a
given period (for 8 s in our method) before being released into the second column. This
increases the sensitivity of the method remarkably as compared to traditional GC-MS.
GCxGC-MS technology also improved the separation of compounds as compared to
traditional GC-MS. For example, we found two compounds giving almost identical mass
spectra with isoprene, having only slightly different retention times. These are probably
cis-1,3-pentadiene and trans-1,3-pentadiene which have been detected earlier in exhaled
breath samples [47,48], or 1,4-pentadiene, which has been associated with smoking [49,50].
However, our participants were non-smokers. It is noteworthy that these compounds
can be erroneously identified as isoprene, and therefore interfere the quantification of
isoprene if they are not separated in the analysis. Exhaled breath isoprene has been
studied extensively as a potential biomarker compound for cholesterol synthesis, though
with controversial results [51,52]. It is possible that these compounds have interfered the
quantification of isoprene in some studies.
Although the GCxGC-MS has advantages in sensitivity and selectivity, it also has
drawbacks. Because of its sensitivity, the signal is easily overloaded when both the quan-
tification and identification are challenged. This technology is suitable mainly for detecting
compounds from challenging matrixes (having a multitude of compounds to be separated),
but it is not very convenient for their quantification. The quantitative method should be
optimized for each compound of interest separately, including calibration with breath
mimicking conditions. Therefore, in this study we did not quantify the detected com-
pounds. Exhaled breath VOCs might have multiple sources, and therefore it would be
more relevant to monitor the changes in their levels rather than searching for specific
biomarker compounds. However, nontargeted volatomic analysis can be used to select the
relevant target compounds to monitor.
In total, 86 VOCs were tentatively identified from exhaled breath samples while about
150 VOCs remained unidentified, as their MS spectra were not found in the MS libraries.
This indicates that there might still exist numerous unidentified molecules in the exhaled
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breath because GC-MS is a standard technology for identifying volatile compounds, and
identification is mainly based on the MS libraries.
There is no analytical method available to monitor all the compounds in exhaled breath.
For example, breath sampling method and thermal desorption (TD) adsorbents select
the compounds, and GC column determine which compounds are chromatographically
separated and can be detected. In this study, we chose the polar Nukol column for the first
separative column because we have found it suitable for detecting endogenous gut-related
exhaled breath VOCs [46], and non-polar Zebron ZB-35HT Inferno column for the second
column due to its chemically different stationary phase compared to Nukol. By choosing
other columns or TD adsorbent, different compounds could have been detected. It is
noteworthy that most GC-MS analyses for exhaled breath VOCs are made by using general
purpose nonpolar methylpolysiloxane columns containing 5% phenyl. With our protocol,
we detected some common exhaled breath compounds such as isoprene, acetone, and
ethanol, but we were unable to detect, for example, ammonia and methane (too small to
detect with MS SCAN 35–300 m/z), or short-chain fatty acids (not enough sensitivity with
MS SCAN mode [46]), although these compounds would be interesting in the perspective
of nutrition and gut health [53–55]. We detected some compounds (Table 1; 3,4-dimethyl
heptane, 3-pentanol, and methyl cyclopentane), which have not been reported in exhaled
breath before. However, it should be pointed out that in our study, the identification was
done only by the spectral library match, and was not confirmed with standard molecules
(i.e., tentative identification) or retention indices. Mass spectra can be almost identical for
some compounds, for example, for structural isomers (e.g., 2-methylbutane and n-pentane)
or compounds with same structure with different length of alkyl chain (e.g., undecanal and
tetradecanal). Therefore, the identification of VOCs in this study must be considered with
caution.
Some benzoic acid and phenolic derivatives, as well as furanones, were detected from
exhaled breath samples only after whole grain diets. It is possible that these VOCs are
degradation products of phenolic compounds such as phenolic acids, alkylresorcinols and
lignans from the DF complex in the bran. Phenolic compounds can be metabolized to
various compounds by colonic fermentation and metabolism [56]; for example, benzoic
acid can be formed from rye phenolics [57]. The compounds were detected mostly in the
same exhaled breath samples, which indicate the same origin for these compounds.
Benzoic acid is known to be related to various foods but considered to have relatively
low levels in the alveolar exhaled breath in the fasting state, since it is metabolized by liver
and kidneys to hippurate within a few hours after oral dosing [58]. However, benzoic acid
is formed also from whole grains in gut fermentation, which may explain the elevated
levels in the fasting state in some individuals during WG diets. The exhaled breath samples
were taken in the fasting state, but the fermentation rate may have been varied based on
individual orocecal transit time and timing of eating WG. Estimation of the fermentation
rate by breath hydrogen measurements [59] would be relevant when studying fermentation-
related exhaled breath VOCs.
It´s noteworthy that the GC parameters used were not optimal for benzoic acid and
phthalic acid/anhydride. Both compounds had wide tailing chromatograph peaks. This
did not interfere with the identification of compounds, but may have affected sensitivity in
their detection, and partly explains why these compounds were seen only in a minority of
exhaled breath samples. Other GC parameters or technology should be used for analyzing
these compounds more accurately.
Furanones are known to be formed in chemical reactions during charbroiling and seed
oil cooking, and in Maillard reaction between sugars and amino acids [60,61]. They can
also be metabolized from grain lignans such as matairesinol or 7-hydroxymatairesinol, or
from enterolactone, a mammalian lignan, which is formed in the large intestine from plant
lignans [62]. All these lignans have dihydro-2(3H)-furanone in their molecule structure.
Enterolactone is considered a biomarker for high lignan intake in the diet [63], but high in-
terindividual variation has been found in its absorption and metabolism [64]. To our knowl-
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edge, 5-dodecyldihydro-(3H)-furanone (CAS 730-46-1, also known as γ-palmitolactone),
dihydro-4-hydroxy-2(3H)-furanone (CAS 5469-16-9, 3-hydroxy-γ-butyrolactone) or dihydro-
5-tetradecyl-2(3H)-furanone (CAS 502-26-1, γ-stearolactone) have not been detected from
exhaled breath before, unlike some other furanones [25,41]. Dihydro-5-tetradecyl-2(3H)-
furanone has been detected from skin [25]. It would be interesting to monitor exhaled
breath phenolic and furanone compounds and their levels in relation to different dietary
sources, for example rye, using optimized analysis methodology for those compounds.
In this study, the randomized crossover protocol was used because the inter-individual
variation of breath VOCs is known to be high [26]. In a crossover protocol, it is more
likely that detected differences in breath VOCs are due to dietary changes because the
other lifestyle factors are rather constant. Furthermore, most of the study participants
were students or staff members of the Faculty of Health Sciences in the University of
Eastern Finland and therefore likely to pay more attention to their eating than the average
population in Finland. The participants consumed plenty of fruits and vegetables and
received plenty of DF, and probably also phenolic compounds, also from sources other
than the study breads. Therefore, the supply of DF remained higher than expected during
the WW diets, being in the level of dietary recommendations. However, the total amount
of consumed fruits and vegetables remained stable during the study, and there was a
significant difference in the DF levels between WG and WW diets, as intended.
In conclusion, the GCxGC-MS technology, being sensitive and selective, offered some
advantage for detecting exhaled breath VOCs. Benzoic acid derivatives, phenolic com-
pounds, and furanones are potential compounds in monitoring metabolic effects of whole
grains in exhaled breath. However, based on earlier reports by us [42,43] and others [22],
it seems that it would be more relevant to monitor changes in the levels of multiple com-
pounds or in VOC profiles rather than individual compounds when monitoring diet-related
changes in exhaled breath VOCs.
4. Materials and Methods
4.1. Protocol
A randomized crossover manner dietary intervention was performed with 9 partici-
pants. They followed high-fiber diets containing either whole grain rye bread (WGR) or
whole grain wheat bread (WGW) for 1 week in randomized order, and there were 1-week
periods with refined (white) wheat bread (WW) before both test periods (Figure 1). At the
end of the diet periods, exhaled breath samples in fasting state and parallel background
air samples (room air samples, BG) were analyzed with GCxGC-MS technology. The
RYEBREATH study was approved by the Ethics Committee of the Hospital District of
Northern Savo (University of Eastern Finland, Hannu Mykkänen, 40/2015).




Figure 1. Study design of a randomized crossover manner dietary intervention with 9 participants. 
WW = control diet containing refined wheat bread; WGR = whole grain rye bread diet; WGW = 
whole grain wheat bread diet. Exhaled breath and parallel background room air samples were 
taken at the end of the diet periods. 
4.2. Study Participants 
The participants were recruited into the RYEBREATH study with the campus 
advertisements in the University of Eastern Finland. They were healthy non-smoking 
Finnish men (2) and women (7) aged 21 to 59 years (average 31 years) and with BMI (body 
mass index) between 18.7 and 29 kg/m2 (average 23 kg/m2). The participants were advised 
to maintain their body weight and habitual lifestyle throughout the study, except the 
devised dietary modification for cereal content. All the participants provided written 
informed consent prior to participating in the study. 
4.3. Diets 
Participants followed three diets differing in consumed grain products. They were 
advised to consume 5–7 slices of white wheat bread per day during WW periods, 5–7 slices 
of whole grain rye bread during WGR period and 7–8 slices of whole grain wheat bread 
during WGW period. The commercial breads used in each period were: white toasts 
Vaasan Iso Paahto (DF 0.9 g/slice) and Oululainen Reilu Vehnä (DF 1.2 g/slice) during the 
WW periods, whole grain rye breads Fazer Real Ruis (DF 4.2 g/slice) and Porokylän 
leipomo PikkuKartano (DF 1.6 g/slice) during the WGR period, and wholegrain wheat 
breads Fazer Täysjyvä Paahto (DF 1.5 g/slice) and Vaasan Täysjyvä Isopaahto (DF 2.5 
g/slice) during the WGW period. The study subjects were advised to avoid whole grain 
products during the WW periods and not to consume any rye except during the WGR 
period. Food items which typically increase gut fermentation and fermentative gases in 
the intestines, such as beans, cabbages, and xylitol products, were avoided throughout the 
intervention. A master´s student in clinical nutrition advised the participants weekly on 
the practical management of the diets. The participants filled in 4-day food records during 
each diet period and recorded the eaten amount of the test breads in a daily questionnaire. 
The food records were analyzed for nutrient intakes using the Diet32 software (version 
1.4.6.3, Aivo Finland Oy, Turku, Finland). 
The intakes of energy, protein, fat, and carbohydrates during the test diet periods 
were maintained at the same level during the intervention (Table 3). Only intake of DF 
was significantly different between the WW and WG periods. The participants consumed 
breads on average 159 g/day during the WW periods, 208 g/day during WGR, and 200 
g/day during WGW, which covered 18% of energy intake in WW1, 19% in WW2, 24% in 
WGR, and 23% in WGW. 
  
Figure 1. Study design of a randomized crossover manner dietary intervention with 9 partici-
pants. WW = control diet containing refined wheat bread; WGR = whole grain rye bread diet;
WGW = whole grain wheat bread diet. Exhaled breath and parallel background room air samples
were taken at the end of the diet periods.
Molecules 2021, 26, 2667 7 of 12
4.2. Study Participants
The participants were recruited into the RYEBREATH study with the campus adver-
tisements in the University of Eastern Finland. They were healthy non-smoking Finnish
men (2) and women (7) aged 21 to 59 years (average 31 years) and with BMI (body mass
index) between 18.7 and 29 kg/m2 (average 23 kg/m2). The participants were advised to
maintain their body weight and habitual lifestyle throughout the study, except the devised
dietary modification for cereal content. All the participants provided written informed
consent prior to participating in the study.
4.3. Diets
Participants followed three diets differing in consumed grain products. They were
advised to consume 5–7 slices of white wheat bread per day during WW periods, 5–7 slices
of whole grain rye bread during WGR period and 7–8 slices of whole grain wheat bread
during WGW period. The commercial breads used in each period were: white toasts Vaasan
Iso Paahto (DF 0.9 g/slice) and Oululainen Reilu Vehnä (DF 1.2 g/slice) during the WW
periods, whole grain rye breads Fazer Real Ruis (DF 4.2 g/slice) and Porokylän leipomo
PikkuKartano (DF 1.6 g/slice) during the WGR period, and wholegrain wheat breads
Fazer Täysjyvä Paahto (DF 1.5 g/slice) and Vaasan Täysjyvä Isopaahto (DF 2.5 g/slice)
during the WGW period. The study subjects were advised to avoid whole grain products
during the WW periods and not to consume any rye except during the WGR period. Food
items which typically increase gut fermentation and fermentative gases in the intestines,
such as beans, cabbages, and xylitol products, were avoided throughout the intervention.
A master´s student in clinical nutrition advised the participants weekly on the practical
management of the diets. The participants filled in 4-day food records during each diet
period and recorded the eaten amount of the test breads in a daily questionnaire. The food
records were analyzed for nutrient intakes using the Diet32 software (version 1.4.6.3, Aivo
Finland Oy, Turku, Finland).
The intakes of energy, protein, fat, and carbohydrates during the test diet periods
were maintained at the same level during the intervention (Table 3). Only intake of DF
was significantly different between the WW and WG periods. The participants consumed
breads on average 159 g/day during the WW periods, 208 g/day during WGR, and
200 g/day during WGW, which covered 18% of energy intake in WW1, 19% in WW2, 24%
in WGR, and 23% in WGW.
Table 3. Mean daily intakes 1 of energy and nutrients during the 1-week diet periods (n = 9).
WW1 WW2 WGR WGW p-Value 2
Energy, MJ 9.0 ± 1.7 9.3 ± 1.6 9.0 ± 1.8 9.0 ± 1.5 0.865
Carbohydrates, E% 42 ± 2 41 ± 4 42 ± 3 41 ± 4 0.706
Protein, E% 20 ± 3 20 ± 3 19 ± 2 20 ± 3 0.254
Fat, E% 35 ± 4 36 ± 5 35 ± 4 35 ± 7 0.954
Dietary fiber, g 24 ± 8 25 ± 8 36 ± 6 * 34 ± 1 * <0.001
1 Values are means ± SD; 2 Statistical significance of the difference among the diet periods analyzed with
Friedman’s test; * Different from WW periods, Wilcoxon´s test, p = 0.008; WW = diet with white wheat bread;
WGR = whole grain rye bread diet; WGW = whole grain wheat bread diet; E% = percentage of total energy intake.
4.4. Exhaled Breath Analysis
End-tidal exhaled breath samples were taken with Bio-VOC® samplers (Markes In-
ternational Ltd., UK), which are made for capturing the last part of exhaled breath from
the alveoli concentrated with VOCs excreted from the circulation (Figure 2a). Participants
were trained to give an adequate sample. Before the sampling, participants brushed their
teeth with toothpaste and rinsed the mouth effectively with water to stabilize the microbial
fermentation in the mouth. They were sitting still without talking and breathing normally
for a few minutes before sampling to standardize the ventilation. Then they gave a con-
stant deep blow through the sampler. Exhaled breath samples were injected immediately
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after sampling into TD liners (fritted glass liner packed with Tenax GR, mesh 80–100, GL
Sciences, Eindhoven, The Netherlands) using the Bio-VOC® sampler as a gas syringe
and adapter (self-made by sculpting from PTFE rod) to connect the sampler and the liner
tightly (Figure 2b). The TD liner was closed with a storage cap (Brass Liner Blanking Cap,
GL Sciences, Eindhoven, the Netherlands) and analyzed within 2–5 h (Figure 2c). The
internal standard (1 µL 0.22 µg/µL acetone-d6 (Euriso-top, Saint-Aubin, France) in Milli-Q
ultrapure water (Millipore, Bedford, MA, USA)) was injected to the TD liners 30–60 min
before sampling by using gas tight syringe and the Bio-VOC® sampler. The background
room air samples were taken before breath samples by injecting the room air with the
Bio-VOC® sampler to the TD liners. The room air samples were otherwise handled in the
same way as breath samples.
Analysis was performed with a GCxGC-MS device consisting of GCMS-QP2010 Ultra
and AOC-5000 Plus injection system (Shimadzu Scientific Instruments, Columbia, MD,
USA), Optic-4 multi-mode inlet (GL Science, Eindhoven, The Netherlands) and ZX-1
thermal modulator (Zoex Corporation, Houston, TX, USA) (Figure 2d). The injection
was done with automated injection of AOC-5000 Plus to the inlet of Optic injector. The
temperature of the inlet was at the beginning 35 ◦C for 2 min and then rose to the 200 ◦C
at the rate of 18 ◦C/min. The injection was done in high-pressure mode with split 5
allowing the pressure of the inlet decrease temporarily during the injection. The injected
sample was preconcentrated to the cryotrap after the injector at −100 ◦C for 7 min and
released rapidly at 200 ◦C (temperature rise 60 ◦C/s) to the GC. VOCs were separated
on two serial capillary columns; polar Nukol (0.25 µm thick phase, 0.25 mm internal
diameter, 30 m long, Supelco, Bellefonte, PA, USA) and non-polar Zebron ZB-35HT Inferno
(0.8 µm/0.18 mm/1 m, Phenomenex Torrance, CA, USA), separated by a cryogenic Zoex-
modulator. The modulation was done with 8 s modulation time and 10–30% filling of the
5 L dewar of the liquid nitrogen. Carrier gas was Helium 4.6 (AGA, Espoo, Finland) with
column pressure 150 kPa, column flow 2.14 mL/min, and linear velocity 45.5. The GC oven
was programmed to be 35 ◦C for 10 min, then raised by 3 ◦C/min to 200 ◦C. The duration
of the GC program was 70 min. The detection was done with MS SCAN 35–300 m/z, event
time 0.02 s, and scan speed 20,000 unit/s. Temperature of the ion source was 200 ◦C and
for MS interface 220 ◦C.
The data were analyzed using ChromSquare 2.2 data analysis software (Chromaleont,
Messina, Italy). All the visible blobs in two-dimensional chromatograph were manually
selected for identification. The tentative identification was performed by comparing their
mass spectra with data from NIST 11 Mass Spectral library (The National Institute of
Standards and Technology, Gaithersburg, MD, USA), Wiley Registry 10th Edition (John
Wiley & Sons, Hoboken, NJ, USA), and Flavour & Fragrance Natural & Synthetic Com-
pounds GCMS library FFNSC 2 (Shimadzu Corp., Kyoto, Japan). The identification was
checked precisely for each blob by the researcher, but it was not confirmed with analytical
standards or retention indices. Tentatively identified VOCs were reported only if they
were found in more than a single exhaled breath sample. Four exhaled breath samples
and five background room air samples were excluded because of technical problems in
the GC-MS analysis. Siloxanes and polyethylene glycol compounds were excluded from
analysis because they likely originate from column phases.
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Figure 2. Exhaled breath analysis. End-tidal exhaled breath was sampled with the Bio-VOC®
sampler (a), injected into a glass liner containing Tenax GR absorbent (b), removed to laboratory in
a sealed liner (c), and analyzed ith co prehensive t o-di ensional gas chromatography–mass
spectrometry (d).
5. Conclusions
Exhaled breath VOCs reflect metabolism and lifestyle, thus having large interindivid-
ual variation and a lot of so far unidentified molecules. Since diet affects exhaled breath
VOCs, they could be utilized in studying the metabolic effects of diets. The GCxGC-MS
technology offers some advantage in making the detection of human VOCs sensitive and
selective. Exhaled breath benzoic acid derivatives, phenolic compounds, and furanones
are interesting compounds to study further when exploring the metabolic effects of whole
grains.
Supplementary Materials: The following are available online, Table S1: The detected VOCs (86)
with tentative identification 1 from exhaled breath samples (n = 32) of nine study participants.
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